← Back to Analyst Consensus 
HSCS Buy
HeartSciences Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 24, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 22, 2025 | Ascendiant Capital | maintain | Buy → Buy | $9.2 | 38% |
| Oct 1, 2025 | Ascendiant Capital | maintain | Buy → Buy | $9 | 38% |
| Mar 18, 2025 | Ascendiant Capital | maintain | Buy → Buy | $14 | 38% |
| Dec 18, 2024 | Maxim Group | reiterate | Buy → Buy | $12 | 42% |
| Sep 23, 2024 | Ascendiant Capital | reiterate | Buy → Buy | $15 | 38% |
| Jan 30, 2023 | Ascendiant Capital | initiate | — → Buy | $3.3 | 38% |
| Dec 19, 2022 | Maxim Group | maintain | — → Buy | $3 | 42% |
| Nov 9, 2022 | Maxim Group | initiate | — → Buy | $8 | 42% |
| Aug 8, 2022 | Benchmark | initiate | — → Speculative Buy | $8 | 54% |
Price Target Trend
Jun 10, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days